Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

Thermobalancing therapy is safe and effective for treating enlarged prostates.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Finasteride treats hair loss and reduces prostate cancer risk.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Finasteride affects male rat genitalia development, causing abnormalities during specific pregnancy days.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Certain drugs that block specific enzymes can help treat prostate diseases.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Finasteride reduces male rat fertility by causing issues with copulatory plug formation.

Using finasteride with TIP extends time off period for prostate cancer patients.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.